continuous monitoring and reporting is essential, as well as significant consequences for failing to comply.
Failure to comply must have significant consequences.
Bombardier suggested that in addition to evaluation, this research should develop ways to mitigate legal, privacy, and confidentiality problems associated with screening and treatment.